Indeed, some studies have found that SGLT2 inhibitors lower renal tissue AGT expression (Han et al., 2018), whereas others have shown the opposite (Wang et al., 2017b) using the same diabetes mouse model. Here, SLC5A2 is linked to diabetes mellitus.